FDA Issues Compliance Warnings to Breast Implant Manufacturers

The US Food and Drug Administration (FDA) issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under their premarket approval orders, to conduct post-approval studies to assess the long-term safety and risks of their silicone gel-filled breast implants.